MHC studies of the primary antiphospholipid antibody syndrome and of antiphospholipid antibodies in systemic lupus erythematosus

Journal of Rheumatology

Volumn 23, Issue 7, 1996, Pages 1173-1179

  Goldstein, Rose ^a   Moulds, Joann M ^a   Douglas Smith, C ^a   Sengar, Dharmendra P S ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Antiphospholipid antibody; Major histocompatibilitycomplex; Systemic lupus erythematosus

Indexed keywords

CARDIOLIPIN ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B8 ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA DR4 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; PHOSPHOLIPID ANTIBODY;

AGAR GEL ELECTROPHORESIS; ALLOTYPE; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE DELETION; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOUTHERN BLOTTING; SYSTEMIC LUPUS ERYTHEMATOSUS;

ALLELES; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; COMPLEMENT C4A; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0029681572     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Pétri M, Rheinschmidt M, Whiting-O'Keefe Q, Hellman D, Corash L: The frequency of lupus anticoagulant in systemic lupus erythematosus. Ann Intern Med /9S7,-106:524-31.
2. Love PE, Santoro SA: Antiphospholipid antibodies: Anticardiolipin and thé lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 7990;! 12:682-98.
3. Hazeltine M, Rauch J, Danoff D, Esdaile JM, Tannenbaum H: Antiphospholipid antibodies in systemic lupus erythematosus: Evidence of an association with positive Coombs' and hypocomplementemia. J Rheumatol 7958/15:80-6.
4. Kalunian KC, Peter JB, Middlekauff HR, et al: Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Am J Med 7988/85:602-8.
5. Vianna JL, Khamashta MA, Ordi-Ros J, et al: Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patients. Am J Med 7994/96:3-9.
6. Asherson RA, Khamashta MA, Ordi-Ros J, et al: The "primary" antiphospholipid syndrome: Major clinical and serological features. Medicine [Baltimore] 7989/68:366-74.
7. Sammaritano LR, Gharavi AE, Lockshin MD: Antiphospholipid antibody syndrome: Immunological and clinical aspects. Semin Arthritis Rheum 7990/20:81-96.
8. Arnett FC, Reveille JD: Genetics of systemic lupus erythematosus. Rheum Dis Clin North Am 7992;18:865-92.
9. Hamilton RG, Harley JB, Bias WB, et al: Two Ro(SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR specificities with quantitative expression of Ro(SS-A) autoantibody. Arthritis Rheum 7988/31:496-505.
10. Harley JB, Reichlin M, Arnett FC, Alexander EL, Bias WB, Provost TT: Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science 79S6;232:1145-7.
11. Reveille JD, MacLeod MJ, Whittington K, Arnett FC: Specific amino acid residues in the second hypervariable regions of HLADQA1 and DQB1 chain genes promote the Ro(SS-A)/La(SS-B) autoantibody responses. J Immunol 1991 ,-146:3871-6.
12. Mackworth-Young CG, Chan J, Harris N, et al: The incidence of anticardiolipin antibodies in relatives of patients with systemic lupus erythematosus. J Rheumatol 1987; 14:723-6.
13. Dagenais P, Urowitz MB, Gladman DD, Norman CS: A family study of the antiphospholipid syndrome associated with other autoimmune diseases. J Rheumatol 7992/19:1393-6.
14. Exner T, Barber S, Kronenberg H, Richard KA: Familial association of the lupus anticoagulant. Br J Haematol 7950/45:89-96.
15. Matthey F, Walshe K, Mackie U, Machin SJ: Familial occurrence of the antiphospholipid syndrome. J Clin Pathol 7989/42:495-7.
16. Ford PM, Brunei D, Lillicrap DP, Ford SE: Premature stroke in a family with lupus anticoagulant and antiphospholipid antibodies. Stroke 1990/21:66-71.
17. May KP, West SG, Moulds J, Kotzin BL: Different manifestations of the antiphospholipid antibody syndrome in a family with systemic lupus erythematosus. Arthritis Rheum 7993;36:528-33.
18. Savi M, Ferraccioli GF, Neri TM, et al: HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus. Arthritis Rheum /988/31:1568-70.
19. McHugh NJ, Maddison PJ: HLA-DR antigens and anticardiolipin antibodies in patients with systemic lupus erythematosus (letter). Arthritis Rheum 1989;32:1623-.
20. Arnett FC, Olsen ML, Anderson KL, Reveille JD: Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant. J Clin Invest ./99/;87:1490-5.
21. Wilson WA, Perez MC, Michalski JP, Armatis PE: Cardiolipin antibodies and null alleles of C4 in black Americans with systemic lupus erythematosus. J Rheumatol 1988; 15:1768-72.
22. McNeil HP, Gavaghan TP, Krilis SA, Geczy AF, Chesterman CN: HLA-DR antigens and anticardiolipin antibodies (letter). Clin Exp Rheumatol 1990; 8:425-7.
23. Tan EM, Cohen AS, Fries JF, et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 79S2;25:1271-7.
24. Harris EN, Gharavi AE, Patel SP, Hughes GRV: Evaluation of the anticardiolipin test: Report of an international workshop held 4 April 1986. Clin Exp Immunol /987;68:215-22.
25. Patel PI, Nussbaum RL, Framson PE, Ledbetter DH, Caskey CT, Chinault AC: Organization of the HPRT gene and related sequences in the human genome. Som Cell Mol Genet ;9S4;10:483-93.
26. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol /975;98:503-17.
27. Larhammer D, Schenning L, Gustaffsson K, Claesson L, Rask L, Peterson PA: Complete amino acid sequence of an HLA-DR antigen-like chain as predicted from the nucleotide sequence: Similarities with immunoglobulins and HLA-A, -B and -C antigens. Proc Natl Acad Sei USA /982;79:3687-91.
28. Long EO, Wake CT, Gorski J, Mach B: Complete sequence of an HLA-DR chain deduced from a cDNA clone and identification of multiple non-allelic DR chain genes. EMBO J 7983,-2:389-94.
29. Trowsdale J, Lee J, Carey J, Grosveld F, Bodmer J, Bodmer WF: Sequences related to HLA-DR a chain on human chromosome 6: Restriction enzyme polymorphism detected with DC a chain probes. Proc Natl Acad Sei USA 1983;%0:1972-6.
30. Martell M, Marcadet A, Cohen D: HLA Class II typing by the workshop defined RFLP specificities in unrelated individuals, In: Dupont B, ed. Immunobiology of HLA 1989; 1:943-52.
31. Goldstein R, Duvic M, Targoff IN, et al: HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis. Arthritis Rheum 1990;33:1240-8.
32. Zetterquist H, Olerup O: Identification of HLA-DRB1 04, -DRB1 07, and -DRB1 -09 alleles by PCR amplification with sequence-specific primers. Hum Immunol 7992;34:64-74.
33. Carroll MC, Palsdottir A, Belt KT, Porter RR: Deletion of complement C4 and 21-hydroxylase genes in the HLA class III region. EMBO J /94:2547-52.
34. Belt KT, Carroll MC, Porter RR: The structural basis of the multiple forms of human complement component C4. Cell 1984,-36:907-14.
35. Goldstein R, Sengar DPS: Comparative study of the major histocompatibility complex in French Canadians and non-French Canadians with systemic lupus erythematosus. Arthritis Rheum /995;36:1121-7.
36. Scully LJ, Toze C, Sengar DPS, Goldstein R: Early-onset autoimmune hepatitis is associated with a C4A gene deletion. Gastroenterology 1993;\M:\41$-84.
37. Awdeh ZL, Alper CA: Inherited structural polymorphism of the fourth component of complement. Proc Natl Acad Sei USA ;9S0,-77:3576-80.
38. Sim E, Cross SJ: Phenotyping of human complement component C4, a class III antigen. Biochem J 79S6;239:763-7.
39. Mauff G, Alper CA, Awdeh ZL, et al: Statement on the nomenclature of human C4 allotypes. Immunobiology /9164:184-91.
40. Moulds JM, Arnett FC, Giles CG, Hamilton RG: A novel immunoassay for the quantitation of human C4 gene products. Complement Inflamm ;990;7:95-101.
41. Schur PH, Marcus-Bagley D, Awdeh ZL, Yunis EI, Alper CA: The effect of ethnicity on major histocompatibility complex complement allotypes and extended haplotypes in patients with systemic lupus erythematosus. Arthritis Rheum /990;33:985-92.
42. Asherson RA, Doherty DG, Vergani D, Khamashta MA, Hughes GRV: Major histocompatibility complex associations with primary antiphospholipid syndrome. Arthritis Rheum I992;35:124-5.